Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (313)	1/15/2000 1:09:00 AM
From: Miljenko Zuanic	Read Replies (1) of 427

Peter, From list of 20 larger shorts (thanks for list), I can understand weak rationale for some of the stocks, but none for ALKS. The near future of the company depend on ProRelease-EPO formulation and MediSorb-Risperidone. Because ProLease seams to work fine and they (J&J) are well into PIII trial (and ready to start MediSorb PIII), the IRATIONALE must be that this technologies is crapshot. I can't believe that this all ALKS short are hedge position??? Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next